Geldenhuys, H., Mearns, H., Miles, D. J., Tameris, M., Hokey, D., Shi, Z., Bennett, S., Andersen, P., Kromann, I., Hoff, S. T., Hanekom, W. A., Mahomed, H., Hatherill, M., Scriba, T. J., van Rooyen, M., Bruce McClain, J., Ryall, R., de Bruyn, G., & Group, t. H. T. S. (2015). the tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial. Vaccine, 33(30), 3592–3599. http://access.bl.uk/ark:/81055/vdc_100025936970.0x000035